Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

36.53
Delayed Data
As of Dec 02
 -0.04 / -0.11%
Today’s Change
36.41
Today|||52-Week Range
66.55
-44.35%
Year-to-Date
TEVA Regular Dividend: TEVA began trading ex-dividend on 12/01/16. A $0.34 dividend will be paid to shareholders of record as of 12/05/16.
The Sole Reason Teva Pharmaceutical Industries Ltd. Sank 12% in November
Dec 02 / MotleyFool.com - Paid Partner Content
Some 'January Effect' Stock Picks
Nov 28 / TheStreet.com - Paid Partner Content
Teva Is a Hold
Nov 30 / GuruFocus News - Paid Partner Content
Teva's Leukemia Drug Gets EU Approval in First-Line Setting
Nov 22 / Zacks.com - Paid Partner Content
Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
Nov 30 / TheStreet.com - Paid Partner Content
Allergan's Fibristal Approved in Canada for Label Expansion
Nov 22 / Zacks.com - Paid Partner Content
What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
Nov 29 / MotleyFool.com - Paid Partner Content
Top Research Reports for 21st November, 2016
Nov 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close36.57
Today’s open36.70
Day’s range36.41 - 37.11
Volume6,924,116
Average volume (3 months)8,267,078
Market cap$37.1B
Dividend yield3.72%
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-5.11%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-3.22%
P/E ratio21.1
Price/Sales2.89
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.06+0.19%
OASMOasmia Pharmaceutica...0.000.00%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.37
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts


Search for Jobs